Effects of soy isoflavone and endogenous oestrogen on breast cancer in MMTV-erbB2 transgenic mice

Journal of International Medical Research

Volumn 40, Issue 6, 2012, Pages 2073-2082

  Zhang, G P ^a   Han, D ^a   Liu, G ^a   Gao, S G ^a   Cai, X Q ^a   Duan, R H ^a   Feng, X S ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Breast cancer; Endogenous oestrogen; Immunohistochemistry; MMTV erbB2 transgenic mice; Ovariectomized; Soybean isoflavones; Vascular endothelial growth factor (VEGF)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; ISOFLAVONE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INHIBITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; SOYBEAN; TRANSGENIC MOUSE; TUMOR VOLUME;

EID: 84872238921     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006051204000604     Document Type: Article

References (34)

1. Velentzis LS, Cantwell MM, Cardwell C, et al: Lignans and breast cancer risk in pre- and postmenopausal women: meta-analyses of observational studies. Br J Cancer 2009; 100: 1492-1498.
2. Crandall CJ, Aragaki AK, Chlebowski RT, et al: New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk. Arch Intern Med 2009; 169: 1684-1691.
3. Beral V, Reeves G, Bull D, et al: Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst 2011; 103: 296-305.
4. Bernstein L, Yuan JM, Ross RK, et al: Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer casecontrol studies. Cancer Causes Control 1990; 1: 51-58.
5. Wood CE, Register TC, Franke AA, et al: Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res 2006; 66: 1241-1249.
6. Setchell KD: Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 2001; 20(suppl 5): 354S-362S.
7. Kurzer MS: Phytoestrogen supplement use by women. J Nutr 2003; 133: 1983S-1986S.
8. Dos Santos Silva I, Mangtani P, McCormack V, et al: Phyto-oestrogen intake and breast cancer risk in South Asian women in England: findings from a population-based case-control study. Cancer Causes Control 2004; 15: 805-818.
9. Wu AH, Wan P, Hankin J, et al: Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002; 23: 1491-1496.
10. Yamamoto S, Sobue T, Kobayashi M, et al: Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 2003; 95: 906-913.
11. Badger TM, Ronis MJ, Simmen RC, et al: Soy protein isolate and protection against cancer. J Am Coll Nutr 2005; 24: 146S-149S.
12. Miksicek RJ: Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 1994; 49: 153-160.
13. Mueller SO, Simon S, Chae K, et al: Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor α (ERα) and ER β in human cells. Toxicol Sci 2004; 80: 14-25.
14. Ju YH, Allred CD, Allred KF, et al: Physiological concentrations of dietary genistein dosedependently stimulate growth of estrogendependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J Nutr 2001; 131: 2957-2962.
15. Wang TT, Sathyamoorthy N, Phang JM: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996; 17: 271-275.
16. Foth D, Cline JM: Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr 1998; 68(suppl 6): 1413S-1417S.
17. Tansey G, Hughes CL Jr, Cline JM, et al: Effects of dietary soybean estrogens on the reproductive tract in female rats. Proc Soc Exp Biol Med 1998; 217: 340-344.
18. Yang X, Edgerton SM, Kosanke SD, et al: Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res 2003; 63: 2425-2433.
19. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al: A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995; 87: 190-197.
20. Thomas HV, Key TJ, Allen DS, et al: A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women on the island of Guernsey. Br J Cancer 1997; 76: 401-405.
21. Key TJ: Serum oestradiol and breast cancer risk. Endocr Relat Cancer 1999; 6: 175-80.
22. Cho YA, Kim J, Park KS, et al: Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status. Eur J Clin Nutr 2010; 64: 924-932.
23. Richter DU, Abarzua S, Chrobak M, et al: Effects of phytoestrogen extracts isolated from flax on estradiol production and ER/PR expression in MCF7 breast cancer cells. Anticancer Res 2010; 30: 1695-1699.
24. Pike AC, Brzozowski AM, Hubbard RE, et al: Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999; 18: 4608-4618.
25. Zhang C, Ho SC, Lin F, et al: Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status. Cancer Sci 2010; 101: 501-507.
26. Zhang M, Liu X, Holman CD: Effect of dietary intake of isoflavones on the estrogen and progesterone receptor status of breast cancer. Nutr Cancer 2010; 62: 765-773.
27. Limer JL, Speirs V: Phyto-oestrogens and breast cancer chemoprevention Breast Cancer Res 2004: 6: 119-127.
28. Hirose K, Imaeda N, Tokudome Y, et al: Soybean products and reduction of breast cancer risk a case-control study in Japan. Br J Cancer 2005; 93: 15-22.
29. Rock BJ, Hilakivi Clarke L, Clarke R: Metaanalysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006; 98: 459-471.
30. Key TJ, Appleby PN, Reeves GK, et al: Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95: 1218-1226.
31. Dai Q, Franke AA, Yu H, et al: Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics. Cancer Epidemiol Biomarkers Prev 2003; 12: 497-502.
32. Xu WH, Zheng W, Xiang YB, et al: Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ 2004; 328: 1285.
33. Hu JW, Zhao XH, Zhang YM, et al: Effect of soy isoflavones on the incidence of 7, 12- dimethylbenz (alpha) anthracene-induced breast tumors in rats. Beijing Da Xue Xue Bao 2010 Jun 18; 42: 288-292 [in Chinese, English abstract].
34. Newcomb PA, Titus-Ernstoff L, Egan KM, et al: Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 593-600.